Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £266 million in external investment has been raised by Oxford University Innovation spinouts since 2000, and five are currently listed on London’s AIM market.

The creation of these new spinout companies also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2002

BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.

Incorporated in November 2002

Origin: Oxford University, Department of Pathology

Contact: James Mallinson

Oxford Risk is the market-leading provider of customer risk profilers. Their products reveal the level of risk customers are willing and able to take with their financial investments.

Incorporated in November 2002

Origin: Oxford University, Nuffield Department of Population Health

Contact: James Mallinson

Oxford Immunotec is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology.

Incorporated in October 2002

Origin: Oxford University, Nuffield Department of Clinical Medicine

Contact: James Mallinson

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation